IntegraGen Genomics offers access to the latest innovative technologies in molecular biology enabling you to implement your genomic research projects and also develops partnerships and collaborations with leading academic and industrial researchers.

Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN

Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN to acquire all outstanding shares at a price of 2.20€ per share. This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of (…)  » 

What’s new with MERCURY?

Our latest release: MERCURY™ v3.0

We are excited to provide you with important information regarding the release of a new version (v3.0) of MERCURY™. This updated version of MERCURY has a number of changes and improvements designed to enhance data analysis capabilities and the user experience.

 » 

IntegraGen Achieves CE Mark for Its MERCURY™ Cloud-based Software Tool Which Supports Molecular Tumor Profiling for Cancer Patients

IntegraGen announces the company’s MERCURY™ cloud-based analytical software tool has achieved Conformité Européenne (CE) marking. This registration enhances the ability for IntegraGen sell MERCURY throughout the European Union (EU). MERCURY is utilized by researchers and clinicians to assist with the analysis of sequencing data derived from small (…)  » 

IntegraGen Update – Still open to meet your research needs

IntegraGen is following the French Government’s recommendations and precautionary measures for COVID-19. As an essential supplier of genomic research services, we are committed to meeting the needs of our customers while also making every effort to protect the health and well-being of our employees and their families.

We have undertaken (…)  » 

COVID-19 update: IntegraGen remains committed to meeting our customers needs

Dear IntegraGen partner and customer,

We value your well-being and understand that the entire community is impacted by the novel coronavirus (COVID-19) outbreak. This is why we are committed to providing consistent and timely support so your important work is not interrupted.

IntegraGen is closely monitoring guidance from health authorities (…)  » 

IntegraGen Genomics seminar – From high throughput genomic data generation to high level interpretation, an industrial experience of NGS services. 12 April 2019 – Paris, France

IntegraGen Genomics is pleased to present:

 

From high throughput genomic data generation to high level interpretation, an industrial experience of NGS services.

Simplify your RNA-SEQ study from data production to gene expression analysis Get access to the most experienced EXOME sequencing company DNA methylation: discover (…)  » 

IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers

IntegraGen has announced it is collaborating with Google Cloud for the implementation of IntegraGen’s advanced genomic analysis tools, SIRIUS™ and MERCURY™ into the Google Cloud Platform. This partnership will enable widespread online availability, rapid data transfer and enhanced data security to clinicians and researchers utilizing these analytical tools.

(…)  » 
Page 1/3 1 2 3